Contact

All Stories

  1. Exploring elastin-like polypeptide tags and mini-intein for recombinant protein purification in Leishmania tarentolae

    Article • Protein Expression and Purification, July 2026, Elsevier

    Dr Mariela Bollati-Fogolin

  2. Insights into the Chemico‐Biological Interactions of Natural Sesquiterpene Lactones with the Thiol‐Redox Metabolism of Pathogenic Trypanosomatids

    Article • ChemMedChem, April 2026, Wiley

    Dr Mariela Bollati-Fogolin

  3. Protocol to enhance pre-sexual and sexual differentiation of Toxoplasma gondii using retinal cells and intestinal organoid-derived monolayers

    Article • STAR Protocols, March 2026, Elsevier

    Dr Mariela Bollati-Fogolin

  4. Cyt‐Geist: Current and Future Challenges in Cytometry: Reports of the CYTO 2025 Conference Workshops

    Article • Cytometry Part A, December 2025, Wiley

    Dr Mariela Bollati-Fogolin

  5. Chemical Profile and In Vitro Protective Effects of Minthostachys verticillata (Griseb.) Epling Aqueous Extract in Intestinal Inflammatory Environments

    Article • Plants, December 2025, MDPI AG

    Dr Mariela Bollati-Fogolin

  6. Enhancing pre-sexual and sexual differentiation of Toxoplasma gondii using retinal epithelial cells and intestinal organoids

    Article • Cell Reports, October 2025, Elsevier

    Dr Mariela Bollati-Fogolin

  7. A red-shifted biosensor for intracellular detection of cAMP: the CUTieR the better

    Article • Biochemical and Biophysical Research Communications, June 2025, Elsevier

    Dr Mariela Bollati-Fogolin

  8. Chronic heat stress reshapes Russian sturgeon innate immune response to Aeromonas hydrophila challenge

    Article • Fish & Shellfish Immunology, May 2025, Elsevier

    Dr Mariela Bollati-Fogolin

  9. In vitro blastocyst implantation and trophoblast migration are disrupted by the UV filter benzophenone-3 (BP3)

    Article • Environmental Pollution, May 2024, Elsevier

    Dr Mariela Bollati-Fogolin

  10. Expression and functional characterization of chimeric recombinant bovine follicle‐stimulating hormone produced in Leishmania tarentolae

    Article • Microbial Biotechnology, April 2024, Wiley

    Dr Mariela Bollati-Fogolin

  11. Wound healing and anti-oxidant activities induced by an alginate hydrogel-based ointment

    Article • Brazilian Journal of Health Review, October 2023, South Florida Publishing LLC

    Dr Mariela Bollati-Fogolin

  12. What have we learned from a case of convalescent plasma treatment in a two-time kidney transplant recipient COVID-19 patient? A case report from the perspective of viral load evolution and immune response

    Article • Frontiers in Nephrology, June 2023, Frontiers

    Dr Mariela Bollati-Fogolin

  13. Garbage in, garbage out: how reliable training data improved a virtual screening approach against SARS-CoV-2 MPro

    Article • Frontiers in Pharmacology, June 2023, Frontiers

    Dr Mariela Bollati-Fogolin, Carolina Bellera

  14. Exploring Toxoplasma gondii´s Biology within the Intestinal Epithelium: intestinal-derived models to unravel sexual differentiation

    Article • Frontiers in Cellular and Infection Microbiology, May 2023, Frontiers

    Dr Mariela Bollati-Fogolin

  15. Antioxidant Capacity and NF-kB-Mediated Anti-Inflammatory Activity of Six Red Uruguayan Grape Pomaces

    Article • Molecules, May 2023, MDPI AG

    Dr Mariela Bollati-Fogolin, Full Professor of Biochemistry Fabio Polticelli

  16. Chemistry of polyhalogenated nitrobutadienes, 19: synthesis of new types of compounds modulating the biological activity of type I Interferons (IFN-I).

    Article • ARKIVOC, May 2023, ARKAT USA, Inc.

    Dr Mariela Bollati-Fogolin

  17. Murine colon organoids as a novel model to study Trypanosoma cruzi infection and interactions with the intestinal epithelium

    Article • Frontiers in Cellular and Infection Microbiology, March 2023, Frontiers

    Dr Mariela Bollati-Fogolin

  18. Modeling the human placental barrier to understand Toxoplasma gondii´s vertical transmission

    Article • Frontiers in Cellular and Infection Microbiology, March 2023, Frontiers

    Dr Mariela Bollati-Fogolin

  19. New Nitric Oxide-Releasing Compounds as Promising Anti-Bladder Cancer Drugs

    Article • Biomedicines, January 2023, MDPI AG

    Dr Mariela Bollati-Fogolin

  20. 3r s applied to in vivo biological activity of recombinant human erythropoietin assay

    Article • Biological Models Research and Technology, January 2023, Editora Cubo Multimidia

    Dr Mariela Bollati-Fogolin

  21. PD-1/PD-L1 blockade abrogates a dysfunctional innate-adaptive immune axis in critical β-coronavirus disease

    Article • Science Advances, September 2022, American Association for the Advancement of Science

    Dr Mariela Bollati-Fogolin

  22. Jejunum-derived NF-κB reporter organoids as 3D models for the study of TNF-alpha-induced inflammation

    Article • Scientific Reports, August 2022, Springer Science + Business Media

    Dr Mariela Bollati-Fogolin

  23. Hypoxia and inflammation conditions differentially affect the expression of tissue transglutaminase spliced variants and functional properties of extravillous trophoblast cells

    Article • American Journal of Reproductive Immunology, March 2022, Wiley

    Dr Mariela Bollati-Fogolin

  24. Generation and Characterization of Stable Redox-Reporter Mammalian Cell Lines of Biotechnological Relevance

    Article • Sensors, February 2022, MDPI AG

    Dr Mariela Bollati-Fogolin

  25. Antiproliferative activity of two copper (II) complexes on colorectal cancer cell models: Impact on ROS production, apoptosis induction and NF-κB inhibition

    Article • European Journal of Pharmaceutical Sciences, February 2022, Elsevier

    Dr Mariela Bollati-Fogolin

  26. A comparative study of supercritical fluid and ethanol extracts of cannabis inflorescences: Chemical profile and biological activity

    Article • The Journal of Supercritical Fluids, January 2022, Elsevier

    Dr Mariela Bollati-Fogolin

  27. Lactobacillus rhamnosus postbiotic-induced immunomodulation as safer alternative to the use of live bacteria

    Article • Cytokine, October 2021, Elsevier

    Dr Mariela Bollati-Fogolin

  28. Identification and characterization of antioxidant peptides obtained from the bioaccessible fraction of α‐lactalbumin hydrolysate

    Article • Journal of Food Science, September 2021, Wiley

    Dr Mariela Bollati-Fogolin

  29. Ivermectin reduces in vivo coronavirus infection in a mouse experimental model

    Article • Scientific Reports, March 2021, Springer Science + Business Media

    Dr Mariela Bollati-Fogolin

  30. An in vitro model mimicking the complement system to favor directed phagocytosis of unwanted cells

    Article • Electronic Journal of Biotechnology, January 2021, Elsevier

    Dr Mariela Bollati-Fogolin

  31. The Anticancer Peptide CIGB-552 Exerts Anti-Inflammatory and Anti-Angiogenic Effects through COMMD1

    Article • Molecules, December 2020, MDPI AG

    Dr Mariela Bollati-Fogolin

  32. Perinatal exposure to Bisphenol A disturbs the early differentiation of male germ cells

    Article • Reproductive Toxicology, December 2020, Elsevier

    Dr Mariela Bollati-Fogolin

  33. A Nitroalkene Benzoic Acid Derivative Targets Reactive Microglia and Prolongs Survival in an Inherited Model of ALS via NF-κB Inhibition

    Article • Neurotherapeutics, October 2020, Springer Science + Business Media

    Dr Mariela Bollati-Fogolin

  34. Fine-tuning the metabolic rewiring and adaptation of translational machinery during an epithelial-mesenchymal transition in breast cancer cells

    Article • Cancer & Metabolism, July 2020, Springer Science + Business Media

    Dr Mariela Bollati-Fogolin

  35. In Vivo Photodynamic Therapy With a Lipophilic Zinc(II) Phthalocyanine Inhibits Colorectal Cancer and Induces a Th1/CD8 Antitumor Immune Response

    Article • Lasers in Surgery and Medicine, June 2020, Wiley

    Dr Mariela Bollati-Fogolin

  36. The Redox Activity of Protein Disulfide Isomerase Inhibits ALS Phenotypes in Cellular and Zebrafish Models

    Article • iScience, May 2020, Elsevier

    Dr Mariela Bollati-Fogolin

  37. Identification and characterization of human interferon alpha inhibitors through a WISH cell line-based reporter gene assay

    Article • Bioorganic Chemistry, January 2020, Elsevier

    Dr Mariela Bollati-Fogolin

  38. Mitofusins modulate the increase in mitochondrial length, bioenergetics and secretory phenotype in therapy-induced senescent melanoma cells

    Article • Biochemical Journal, September 2019, Portland Press Ltd.

    Dr Mariela Bollati-Fogolin

  39. Generation of stable reporter breast and lung cancer cell lines for NF-κB activation studies

    Article • Journal of Biotechnology, August 2019, Elsevier

    Dr Mariela Bollati-Fogolin

  40. New red-shifted fluorescent biosensor for monitoring intracellular redox changes

    Article • Free Radical Biology and Medicine, April 2019, Elsevier

    Dr Mariela Bollati-Fogolin

  41. Cell Penetrating Capacity and Internalization Mechanisms Used by the Synthetic Peptide CIGB-552 and Its Relationship with Tumor Cell Line Sensitivity

    Article • Molecules, March 2018, MDPI AG

    Dr Mariela Bollati-Fogolin

  42. A green multicomponent synthesis of tocopherol analogues with antiproliferative activities

    Article • European Journal of Medicinal Chemistry, January 2018, Elsevier

    Dr. José M. Padrón, Dr Mariela Bollati-Fogolin

  43. Pro-inflammatory Ca++-activated K+ channels are inhibited by hydroxychloroquine

    Article • Scientific Reports, May 2017, Nature

    Dario Zamboni, Dr Mariela Bollati-Fogolin

  44. Forkhead Box Protein O1 is Linked to Anti-Inflammatory Probiotic Bacteria Acting through Nuclear Factor-κB Pathway

    Article • Journal of Microbial & Biochemical Technology, January 2017, OMICS Publishing Group

    Dr Mariela Bollati-Fogolin

  45. Lactobacillus delbrueckii subsp lactis CIDCA 133 modulates response of human epithelial and dendritic cells infected with Bacillus cereus.

    Article • Beneficial Microbes, November 2016, Wageningen Academic Publishers

    Dr Mariela Bollati-Fogolin

  46. Comparative analysis reveals amino acids critical for anticancer activity of peptide CIGB-552

    Article • Journal of Peptide Science, November 2016, Wiley

    Dr Mariela Bollati-Fogolin

  47. Spectral phasor analysis of LAURDAN fluorescence in live A549 lung cells to study the hydration and time evolution of intracellular lamellar body-like structures

    Article • Biochimica et Biophysica Acta (BBA) - Biomembranes, November 2016, Elsevier

    Dr Mariela Bollati-Fogolin

  48. Screening and characterization of molecules that modulate the biological activity of IFNs-I

    Article • Journal of Biotechnology, September 2016, Elsevier

    Dr Mariela Bollati-Fogolin

  49. New hits as phase II enzymes inducers from a focused library with heteroatom–heteroatom and Michael-acceptor motives

    Article • Future Science OA, November 2015, Future Science

    Dr Vera Lucia Eifler-Lima, Dr Hugo Cerecetto, Dr Mariela Bollati-Fogolin, Fernanda Janarelli

  50. Characterization of Oct4-GFP transgenic mice as a model to study the effect of environmental estrogens on the maturation of male germ cells by using flow cytometry

    Article • The Journal of Steroid Biochemistry and Molecular Biology, November 2015, Elsevier

    Dr Mariela Bollati-Fogolin

  51. Oxidovanadium(IV) complexes with chrysin and silibinin: anticancer activity and mechanisms of action in a human colon adenocarcinoma model

    Article • JBIC Journal of Biological Inorganic Chemistry, September 2015, Springer Science + Business Media

    Dr Mariela Bollati-Fogolin

  52. Data for comparative proteomics analysis of the antitumor effect of CIGB-552 peptide in HT-29 colon adenocarcinoma cells

    Article • Data in Brief, September 2015, Elsevier

    Dr. Yasset Perez-Riverol, Dr Mariela Bollati-Fogolin

  53. Comparative proteomics analysis of the antitumor effect of CIGB-552 peptide in HT-29 colon adenocarcinoma cells

    Article • Journal of Proteomics, August 2015, Elsevier

    Dr. Yasset Perez-Riverol, Dr Mariela Bollati-Fogolin

  54. Quantitation of yeast cell-cell fusion using multicolor flow cytometry

    Article • Cytometry Part A, May 2015, Wiley

    Dr Mariela Bollati-Fogolin

  55. Human Plasmacytoid Dendritic Cells Elicited Different Responses after Infection with Pathogenic and Nonpathogenic Junin Virus Strains

    Article • Journal of Virology, April 2015, ASM Journals

    Dr Mariela Bollati-Fogolin

  56. HT-29 and Caco-2 Reporter Cell Lines for Functional Studies of Nuclear Factor Kappa B Activation

    Article • Mediators of Inflammation, January 2015, Hindawi Publishing Corporation

    Dr Mariela Bollati-Fogolin

  57. Hydration and Supramolecular Organization Studies of Lamellar Bodies in A549 Lung Cells using Laurdan Fluorescence

    Article • Biophysical Journal, January 2015, Elsevier

    Dr Mariela Bollati-Fogolin

  58. Polyoxometalates as antitumor agents: Bioactivity of a new polyoxometalate with copper on a human osteosarcoma model

    Article • Chemico-Biological Interactions, October 2014, Elsevier

    Dr Mariela Bollati-Fogolin

  59. The transcriptional activities and cellular localization of the human estrogen receptor alpha are affected by the synonymous Ala87 mutation

    Article • The Journal of Steroid Biochemistry and Molecular Biology, September 2014, Elsevier

    Dr Mariela Bollati-Fogolin

  60. Antitumor efficacy, pharmacokinetic and biodistribution studies of the anticancer peptide CIGB‐552 in mouse models

    Article • Journal of Peptide Science, July 2014, Wiley

    Dr Mariela Bollati-Fogolin

  61. Evaluation of hexane and ethyl acetate extracts of the spongeJaspis diastracollected from Mauritius Waters on HeLa cells

    Article • Journal of Pharmacy and Pharmacology, April 2014, Wiley

    Dr Mariela Bollati-Fogolin

  62. A new approach for the characterization of proliferative cells in cestodes

    Article • Experimental Parasitology, March 2014, Elsevier

    Dr Mariela Bollati-Fogolin

  63. Antiproliferative and apoptosis-inducing activity of an oxidovanadium(IV) complex with the flavonoid silibinin against osteosarcoma cells

    Article • JBIC Journal of Biological Inorganic Chemistry, November 2013, Springer Science + Business Media

    Dr Mariela Bollati-Fogolin

  64. Mucin-like peptides from Echinococcus granulosus induce antitumor activity

    Article • International Journal of Oncology, June 2013, Spandidos Publications

    Dr Mariela Bollati-Fogolin

  65. Monoclonal antibodies toward different Tn-amino acid backbones display distinct recognition patterns on human cancer cells. Implications for effective immuno-targeting of cancer

    Article • Medical Oncology, April 2013, Springer Science + Business Media

    Dr Mariela Bollati-Fogolin

  66. P02.05 * PHARMACOLOGICAL STABILIZATION OF COMMD1 MEDIATED BY CIGB-552 REGULATES NF-KB/OXIDATIVE STRESS SIGNALING AND INHIBITS LUNG CANCER CELLS GROWTH

    Article • Annals of Oncology, March 2013, Oxford University Press (OUP)

    Dr Mariela Bollati-Fogolin

  67. Antitumor properties of a vanadyl(iv) complex with the flavonoid chrysin [VO(chrysin)2EtOH]2 in a human osteosarcoma model: the role of oxidative stress and apoptosis

    Article • Dalton Transactions, January 2013, Royal Society of Chemistry

    Dr Mariela Bollati-Fogolin

  68. Anti-Inflammatory Lactobacillus rhamnosus CNCM I-3690 Strain Protects against Oxidative Stress and Increases Lifespan in Caenorhabditis elegans

    Article • PLOS One, December 2012, PLOS

    Mr Salvador Genovés, Dr Mariela Bollati-Fogolin

  69. Human monocyte-derived dendritic cells from leukoreduction system chambers after plateletpheresis are functional in an in vitro co-culture assay with intestinal epithelial cells

    Article • Journal of Immunological Methods, October 2012, Elsevier

    Dr Mariela Bollati-Fogolin

  70. WISH cell line: From the antiviral system to a novel reporter gene assay to test the potency of human IFN-α and IFN-β

    Article • Journal of Immunological Methods, July 2012, Elsevier

    Dr Mariela Bollati-Fogolin

  71. Discovery of new orally effective analgesic and anti-inflammatory hybrid furoxanyl N-acylhydrazone derivatives

    Article • Bioorganic & Medicinal Chemistry, March 2012, Elsevier

    Dr Mariela Bollati-Fogolin

  72. Commensal gut flora reduces susceptibility to experimentally induced colitis via T-cell-derived interleukin-101

    Article • Inflammatory Bowel Diseases, October 2011, Wolters Kluwer Health

    Professor Werner Muller, Dr Mariela Bollati-Fogolin

  73. NF-κB Signalling Pathway: Generation and Characterization of a Reporter Cell Line of Human Origin

    Article • July 2011, Springer Science + Business Media

    Dr Mariela Bollati-Fogolin

  74. New reporter cell clones to determine the biological activity of human type I interferons

    Article • BMC Proceedings, January 2011, Springer Science + Business Media

    Dr Mariela Bollati-Fogolin

  75. In vitro and in vivo anticancer properties of a Calcarea carbonica derivative complex (M8) treatment in a murine melanoma model

    Article • BMC Cancer, March 2010, Springer Science + Business Media

    Dr Mariela Bollati-Fogolin

  76. Screening of Natural Compounds Affecting Type I Interferon Signalling

    Article • January 2010, Springer Science + Business Media

    Dr Mariela Bollati-Fogolin

  77. T‐cell‐specific deletion of gp130 renders the highly susceptible IL‐10‐deficient mouse resistant to intestinal nematode infection

    Article • European Journal of Immunology, August 2009, Wiley

    Professor Werner Muller, Dr Mariela Bollati-Fogolin

  78. Temperature shift in CHO Cultures: Effect on Productivity and Product Quality

    Article • Biotechnology Progress, September 2008, Wiley

    Dr Mariela Bollati-Fogolin

  79. Synthetic Mimetics of the gp130 Binding Site for Viral Interleukin-6 as Inhibitors of the vIL-6-gp130 Interaction

    Article • Chemical Biology & Drug Design, March 2008, Wiley

    Professor Werner Muller, Dr Mariela Bollati-Fogolin

  80. Interleukin-10 derived from macrophages and/or neutrophils regulates the inflammatory response to LPS but not the response to CpG DNA

    Article • European Journal of Immunology, December 2006, Wiley

    Professor Werner Muller, Dr Mariela Bollati-Fogolin

  81. Virus free, cell-based assay for the quantification of murine type I interferons

    Article • Journal of Immunological Methods, November 2005, Elsevier

    Professor Werner Muller, Dr Mariela Bollati-Fogolin

  82. Impact of temperature reduction and expression of yeast pyruvate carboxylase on hGM-CSF-producing CHO cells

    Article • Journal of Biotechnology, April 2004, Elsevier

    Dr Mariela Bollati-Fogolin

  83. N- and O-linked carbohydrates and glycosylation site occupancy in recombinant human granulocyte-macrophage colony-stimulating factor secreted by a Chinese hamster ovary cell line

    Article • FEBS Journal, February 2004, Wiley

    Dr Mariela Bollati-Fogolin

  84. Choice of the adequate quantification method for recombinant human GM-CSF produced in different host systems

    Article • Electronic Journal of Biotechnology, December 2002, Elsevier

    Dr Mariela Bollati-Fogolin

  85. Expression of Yeast Pyruvate Carboxylate in hGM-CSF-Producing CHO Cells

    Article • January 2001, Springer Science + Business Media

    Dr Mariela Bollati-Fogolin

  86. 6.2 High Cell Density Cultivation Process

    Article • De Gruyter

    Dr Mariela Bollati-Fogolin

  87. Novel Cell-based Assay for the Detection of Murine type I IfN

    Article • Springer Science + Business Media

    Dr Mariela Bollati-Fogolin